{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:00:51Z","timestamp":1772020851736,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic inflammation causes bone destruction in middle ear cholesteatomas (MECs). However, the causes of their neoplastic features remain unknown. The present study demonstrated for the first time that neoplastic features of MEC are based on proto-oncogene mutations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>DNA was extracted from MEC and blood samples of five patients to detect somatic mutations using depth-depth exome sequencing. Exons with somatic variants were analyzed using an additional 17 MEC\/blood test pairs. Variants detected in MECs but not in blood were considered pathogenic variant candidates. We analyzed the correlation between proto-oncogene (<jats:italic>NOTCH1<\/jats:italic> and <jats:italic>MYC<\/jats:italic>) variants and the presence of bone destruction and granulation tissue formation. <jats:italic>MYC<\/jats:italic> and <jats:italic>NOTCH1<\/jats:italic> variants were detected in two and five of the 22 samples, respectively. Two of the <jats:italic>NOTCH1<\/jats:italic> variants were located in its specific functional domain, one was truncating and the other was a splice donor site variant. Mutations of the two genes in attic cholesteatomas (n\u2009=\u200914) were significantly related with bone destruction (p\u2009=\u20090.0148) but not with granulation tissue formation (p\u2009=\u20090.399).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first study to demonstrate a relationship between neoplastic features of MEC and proto-oncogene mutations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01640-6","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T10:02:22Z","timestamp":1700042542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis"],"prefix":"10.1186","volume":"16","author":[{"given":"Chisei","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-ichiro","family":"Yoshiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Kumai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"1640_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00405-003-0623-x","volume":"261","author":"E Olszewska","year":"2004","unstructured":"Olszewska E, et al. Etiopathogenesis of cholesteatoma. Eur Arch Oto-Rhino-Laryngology. 2004;261:6\u201324.","journal-title":"Eur Arch Oto-Rhino-Laryngology"},{"key":"1640_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21533","author":"AS Alkhaldi","year":"2022","unstructured":"Alkhaldi AS, Alwabili M, Albilasi T, Almuhanna K. Bezold\u2019s abscess: a case report and review of cases over 20 years. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.21533.","journal-title":"Cureus"},{"key":"1640_CR3","first-page":"1","volume":"361","author":"L R\u00fcedi","year":"1979","unstructured":"R\u00fcedi L. Pathogenesis and surgical treatment of the middle ear cholesteatoma. Acta Otolaryngol Suppl. 1979;361:1\u201345.","journal-title":"Acta Otolaryngol Suppl"},{"key":"1640_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/000348947108000312","volume":"80","author":"J Sad\u00e9","year":"1971","unstructured":"Sad\u00e9 J. Cellular differentiation of the Middle ear lining. Ann Otol Rhinol Laryngol. 1971;80:376\u201383.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"1640_CR5","doi-asserted-by":"crossref","unstructured":"Wang NJ et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A 108, 17761\u20136 (2011).","DOI":"10.1073\/pnas.1114669108"},{"key":"1640_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/lary.24890","volume":"125","author":"CL Kuo","year":"2015","unstructured":"Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope. 2015;125:234\u201340.","journal-title":"Laryngoscope"},{"key":"1640_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/coa.12900","volume":"43","author":"BA Jennings","year":"2018","unstructured":"Jennings BA, Prinsley P, Philpott C, Willis G, Bhutta MF. The genetics of cholesteatoma. A systematic review using narrative synthesis. Clin Otolaryngol. 2018;43:55\u201367.","journal-title":"Clin Otolaryngol"},{"key":"1640_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejenta.2012.02.007","volume":"13","author":"M Bassiouny","year":"2012","unstructured":"Bassiouny M, Badour N, Omran A, Osama H. Histopathological and immunohistochemical characteristics of acquired cholesteatoma in children and adults. Egypt J Ear Nose Throat Allied Sci. 2012;13:7\u201312.","journal-title":"Egypt J Ear Nose Throat Allied Sci"},{"key":"1640_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF00176697","volume":"253","author":"J Bujia","year":"1996","unstructured":"Bujia J, Sudhoff H, Holly A, Hildmann H, Kastenbauer E. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol. 1996;253:21\u20134.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1640_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000276789","volume":"58","author":"J Buj\u00eda","year":"1996","unstructured":"Buj\u00eda J, et al. Identification of proliferating keratinocytes in middle ear Cholesteatoma using the monoclonal antibody Ki-67. ORL. 1996;58:23\u20136.","journal-title":"ORL"},{"issue":"9","key":"1640_CR11","doi-asserted-by":"publisher","first-page":"e0239161","DOI":"10.1371\/journal.pone.0239161","volume":"15","author":"DrakskogC de Klerk","year":"2020","unstructured":"de Klerk 11DrakskogC, Westerberg N, M\u00e4ki-Torkko J, Geor\u00e9n E, Cardell SK. Extensive qPCR analysis reveals altered gene expression in middle ear mucosa from cholesteatoma patients. PLoS ONE. 2020;15(9):e0239161.","journal-title":"PLoS ONE"},{"key":"1640_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/01.mao.0000226290.04048.d9","volume":"27","author":"K Ozturk","year":"2006","unstructured":"Ozturk K, Yildirim MS, Acar H, Cenik Z, Keles B. Evaluation of c-MYC status in primary acquired cholesteatoma by using fluorescence in situ hybridization technique. Otol Neurotol. 2006;27:588\u201391.","journal-title":"Otol Neurotol"},{"key":"1640_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/lary.24176","volume":"123","author":"JD Macias","year":"2013","unstructured":"Macias JD, Gerkin RD, Locke D, Macias MP. Differential Gene expression in Cholesteatoma by DNA Chip Analysis. Laryngoscope. 2013;123:1\u2013S21.","journal-title":"Laryngoscope"},{"key":"1640_CR14","doi-asserted-by":"crossref","unstructured":"Palk\u00f3 E et al. The c-MYC Protooncogene Expression in Cholesteatoma. Biomed Res. Int 2014, 1\u20136 (2014).","DOI":"10.1155\/2014\/639896"},{"key":"1640_CR15","doi-asserted-by":"publisher","first-page":"e1389","DOI":"10.1097\/MAO.0000000000003245","volume":"42","author":"A Fukuda","year":"2021","unstructured":"Fukuda A, et al. Notch Signaling in Acquired Middle ear Cholesteatoma. Otol Neurotol. 2021;42:e1389\u201395.","journal-title":"Otol Neurotol"},{"key":"1640_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.pathmechdis.3.121806.154300","volume":"3","author":"JC Aster","year":"2008","unstructured":"Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol. 2008;3:587\u2013613.","journal-title":"Annu Rev Pathol"},{"key":"1640_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0092-8674(91)90064-6","volume":"67","author":"I Rebay","year":"1991","unstructured":"Rebay I, et al. Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell. 1991;67:687\u201399.","journal-title":"Cell"},{"key":"1640_CR18","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1242\/dev.127.14.3185","volume":"127","author":"N Lawrence","year":"2000","unstructured":"Lawrence N, Klein T, Brennan K. Martinez Arias, A. Structural requirements for notch signalling with delta and serrate during the development and patterning of the wing disc of Drosophila. Development. 2000;127:3185\u201395.","journal-title":"Development"},{"key":"1640_CR19","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1073\/pnas.90.9.4037","volume":"90","author":"JF de Celis","year":"1993","unstructured":"de Celis JF, Barrio R, del Arco A, Garc\u00eda-Bellido A. Genetic and molecular characterization of a notch mutation in its Delta- and serrate-binding domain in Drosophila. Proc Natl Acad Sci U S A. 1993;90:4037\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1640_CR20","doi-asserted-by":"publisher","first-page":"32961","DOI":"10.1074\/jbc.274.46.32961","volume":"274","author":"K Shimizu","year":"1999","unstructured":"Shimizu K, et al. Mouse jagged1 physically interacts with notch2 and other notch receptors. Assessment by quantitative methods. J Biol Chem. 1999;274:32961\u20139.","journal-title":"J Biol Chem"},{"key":"1640_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1126\/science.aau3879","volume":"362","author":"I Martincorena","year":"2018","unstructured":"Martincorena I, et al. Somatic mutant clones colonize the human esophagus with age. Science. 2018;362:911\u20137.","journal-title":"Science"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01640-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01640-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01640-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T10:02:25Z","timestamp":1700042545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01640-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01640-6","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Committee for Ethical Issues on Human Genome and Gene Analysis at Nagasaki University (IRB number: 20150501-2), all methods were performed in accordance with the relevant guidelines and regulations. All genetic analyses were performed in the Department of Human Genetics at Nagasaki University. Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"288"}}